SABCS 2021: Genome-based Data for Breast Cancer Risk and Treatment December 3, 2021 In the breast cancer research and clinical communities, one of the biggest events of the year is the San Antonio Breast Cancer Symposium. It’s a place where l... Continue Reading
Why Genetic Testing Should Be Part of Your Mammogram November 26, 2021 Think back to the last time you went in for a mammogram: did anyone ask whether you’d ever taken a genetic test to learn more about your risk of developing br... Continue Reading
My Myriad: Sam Barkat, Engineering October 27, 2021 As we continue our get-to-know-you tour through the Myriad Genetics family, today we sit down with Sam Barkat, Process Sustaining Engineer. She joined the compa... Continue Reading
Breast Cancer Risk Testing for Women of All Ancestries October 23, 2021 October is Breast Cancer Awareness Month, and we are excited about the recent launch of a new approach to risk assessment for hereditary breast cancer. It’s n... Continue Reading
We’re Raising Awareness: Do You Know Your Breast Cancer Risk Profile? October 1, 2021 It’s October, and you know what that means: falling leaves, Halloween, and — of most importance — Breast Cancer Awareness Month! While there’s much bro... Continue Reading
ASCO 2021: Clinical Validation of Breast Cancer Risk Testing for People of All Ancestries July 13, 2021 The Myriad Genetics team, together with leading healthcare collaborators, has been hard at work to expand access to reliable genetic testing results. The result... Continue Reading
ASCO 2021 Preview: Making Breast Cancer Risk Assessment More Inclusive May 20, 2021 We are already looking forward to one of the biggest cancer-focused conferences of the year: the annual meeting of the American Society of Clinical Oncology. Th... Continue Reading
New Publication Demonstrates Value of Combining Clinical and Genetic Risk Models for More Accurate Breast Cancer Risk Prediction January 29, 2021 A new, peer-reviewed paper published in JCO Precision Oncology shows the clear value of incorporating genetic data with existing clinical models to better predi... Continue Reading
Celebrating Breast Cancer Awareness Month October 20, 2020 October is here and it is breast cancer awareness month. I celebrate this month like some people celebrate Halloween or Christmas. Every year, I look forward to... Continue Reading
Myriad’s Commitment to Fight Cancer May 29, 2019 Transforming Patients’ Lives with Pioneering Genetic Tests At Myriad, we are proud of our long-standing commitment to fighting cancer, which continues to exac... Continue Reading
EndoPredict is the Only Test to Answer Three Critical Questions December 7, 2018 EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine... Continue Reading
Genetic Testing Helps Personalize Breast Cancer Treatment Decisions October 1, 2018 According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime. In 2018, about 266,000 new cases of breast... Continue Reading
BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer January 23, 2018 The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas... Continue Reading
Andrea’s story: Cancer prevention can begin with knowing your family history October 10, 2017 Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29 years old. Losing my dad when I was so youn... Continue Reading